Rationale: PARPi Combinations
Rationale for Combining PARP Inhibitors With Other Therapies in Prostate Cancer

Released: April 15, 2021

Expiration: April 14, 2022

Karim Fizazi
Karim Fizazi, MD, PhD
Joaquin Mateo
Joaquin Mateo, MD, PhD

Activity

Progress
1
Course Completed